Literature DB >> 6306489

Amphetamine enhances latent dopaminergic neurotransmission in the rat striatum. Effects on 3H-acetylcholine release.

R Cantrill, S Arbilla, B Zivkovic, S Z Langer.   

Abstract

The electrically evoked, calcium-dependent release of 3H-acetylcholine from slices of rat striatum was inhibited in a concentration-dependent manner by (+)-amphetamine (0.2-20 microM). This inhibitory effect of (+)-amphetamine was unaffected by depletion of the endogenous stores of dopamine by pretreatment with reserpine (5 mg/kg, 24 h). However, the combined treatment of reserpine with alpha-methyl-p-tyrosine (300 mg/kg) or NSD 1015 (100 mg/kg) reduced significantly these inhibitory effects of (+)-amphetamine. Similar results were obtained after chronic 6-hydroxydopamine lesions of the corpus striatum. The inhibition of 3H-acetylcholine release by (+)-amphetamine in rats pretreated with reserpine was potentiated in the presence of 10 microM pargyline. These results support the view that the inhibitory effects of (+)-amphetamine on the electrically-evoked release of 3H-acetylcholine are mediated by dopamine released from a special pool of newly synthetized transmitter rather than through a direct action on an amphetamine recognition site or receptor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6306489     DOI: 10.1007/bf00508350

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.

Authors:  C B SMITH
Journal:  J Pharmacol Exp Ther       Date:  1963-12       Impact factor: 4.030

2.  The phenomenology of experimentally induced amphetamine psychosis--preliminary observations.

Authors:  B M Angrist; S Gershon
Journal:  Biol Psychiatry       Date:  1970-04       Impact factor: 13.382

3.  Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.

Authors:  B Scatton
Journal:  J Pharmacol Exp Ther       Date:  1982-01       Impact factor: 4.030

4.  Presynaptic modulation of the release of dopamine from the rabbit caudate nucleus: differences between electrical stimulation, amphetamine and tyramine.

Authors:  L A Kamal; S Arbilla; S Z Langer
Journal:  J Pharmacol Exp Ther       Date:  1981-03       Impact factor: 4.030

5.  Inhibition by d-amphetamine of the electrically evoked release of [3H]acetylcholine from slices of the rat striatum: involvement of dopamine receptors.

Authors:  R C Cantrill; S Arbilla; S Z Langer
Journal:  Eur J Pharmacol       Date:  1983-01-28       Impact factor: 4.432

6.  Blockade of intravenous amphetamine euphoria in man.

Authors:  L E Jönsson; E Anggård; L M Gunne
Journal:  Clin Pharmacol Ther       Date:  1971 Nov-Dec       Impact factor: 6.875

Review 7.  The actions of amphetamine on neurotransmitters: a brief review.

Authors:  K E Moore
Journal:  Biol Psychiatry       Date:  1977-06       Impact factor: 13.382

8.  Stereoisomers of apomorphine differ in affinity and intrinsic activity at presynaptic dopamine receptors modulating [3H]dopamine and [3H]acetylcholine release in slices of cat caudate.

Authors:  J Lehmann; R V Smith; S Z Langer
Journal:  Eur J Pharmacol       Date:  1983-03-18       Impact factor: 4.432

9.  (+)-Amphetamine binding to rat hypothalamus: relation to anorexic potency for phenylethylamines.

Authors:  S M Paul; B Hulihan-Giblin; P Skolnick
Journal:  Science       Date:  1982-10-29       Impact factor: 47.728

10.  Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit.

Authors:  G Hertting; A Zumstein; R Jackisch; I Hoffmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

  10 in total
  7 in total

1.  Increased uptake sites for serotonin and dopamine with decreased S2 serotonin receptors in microencephalic rat brain.

Authors:  M Watanabe; M Kinuya; G Mamiya; T Tatsunuma; M Nagayoshi; T Matsutani; Y Tsukada
Journal:  Neurochem Res       Date:  1990-10       Impact factor: 3.996

2.  Proceedings of the British Pharmacological Society. 18th-20th December 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

3.  Phenylethylamine-induced release of noradrenaline fails to stimulate alpha 1-adrenoceptors modulating [3H]-acetylcholine release in rat atria, but activates alpha 2-adrenoceptors modulating [3H]-serotonin release in the hippocampus.

Authors:  S Benkirane; S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

4.  Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.

Authors:  K Wedzony; N Limberger; L Späth; T Wichmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

5.  Amphetamine induced release of endogenous dopamine in vitro is not reduced following pretreatment with reserpine.

Authors:  R Niddam; S Arbilla; B Scatton; T Dennis; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

6.  Differential effects of the stereoisomers of 3PPP on dopaminergic and cholinergic neurotransmission in superfused slices of the corpus striatum.

Authors:  S Arbilla; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

7.  Intrastriatal dopaminergic grafts restore inhibitory control over striatal cholinergic neurons.

Authors:  J P Herman; A Lupp; N Abrous; M Le Moal; G Hertting; R Jackisch
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.